Details
Overview:
Dental and medical procedures benefit from the precision and ease of use of the Miltex Lightweight Self-Aspirating Syringe 1.8cc, part number 76-90. This high-quality syringe features a lightweight design that reduces hand fatigue, allowing for comfortable and efficient administration of anesthesia. Its self-aspirating mechanism enhances control and safety during injections.
Specifications:
-
Volume: 1.8 cc
-
Material: Made with lightweight materials for ease of handling.
-
Design: Features a blunt harpoon rod that facilitates aspiration through counterpressure.
-
Grip: Equipped with a palm pad wing grip for improved control and comfort.
-
Connection Type: Luer Lock for secure attachment to needles
-
Use: Ideal for dental procedures requiring reliable and precise aspiration.
Key Features:
-
Lightweight Construction: The lightweight design of the syringe reduces hand fatigue during prolonged use.
-
Blunt Harpoon Rod: Allows for easy aspiration through counter pressure, enhancing safety and efficiency.
-
Palm Pad Wing Grip: Ensures better handling and comfort for the user.
-
Sterility: Each syringe is sterile and intended for single use to maintain hygiene.
This syringe is suitable for various dental applications where precision and reliability are essential. It is frequently used to deliver local anesthetics and other dental treatments.
Manufacturer:
Integra LifeSciences Holdings Corporation is a prominent global medical technology company, specializing in the development and manufacturing of medical devices and tissue products for various surgical applications. The company is dedicated to providing innovative solutions in neurosurgery, reconstructive surgery, and general surgery.
Key Details:
-
Founded: 1989
-
Headquarters: Princeton, New Jersey, USA
-
CEO: Peter Arduini
-
Employees: Over 3,000 globally
-
Stock: Traded on NASDAQ under the ticker symbol IART
Business Focus:
Integra LifeSciences is a leader in neurosurgery, offering a wide range of devices, instruments, and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. The company's product portfolio includes innovative tissue products used for acute wound care, burn treatment, chronic wound management, hernia repair, and peripheral nerve protection and repair.
Key Products and Innovations:
-
Neurosurgery: Products and solutions for neurosurgery, including the Codman Neurosurgery business acquired from Johnson & Johnson in 2017.
-
Dermal Repair: Products like PriMatrix, a dermal repair scaffold used to treat diabetic foot ulcers and burns.
-
Regenerative Medicine: Acquisition of ACell in 2021, enhancing their regenerative medicine capabilities.
Corporate Responsibility:
Integra LifeSciences is committed to limiting uncertainty for surgeons, allowing them to focus on providing the best patient care. The company emphasizes simplifying procedures, involving surgeons in product development, and ensuring the timely delivery and reliability of their products.